Lepu Bio

company

About

Lepu Bio is a Innovation-Driven Biopharmaceutical Company.

  • 251 - 500

Details

Last Funding Type
Series B
Last Funding Money Raised
¥1.29B
Industries
Biotechnology,Health Care,Medical,Service Industry,Therapeutics
Founded date
Jan 1, 2018
Number Of Employee
251 - 500
Operating Status
Active

Lepu Bio they have developed an oncology-focused pipeline of drug candidates, including ADCs, oncolytic virus drugs, and immunotherapies at clinical and pre-clinical stages.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥2.19B
Lepu Bio has raised a total of ¥2.19B in funding over 2 rounds. Their latest funding was raised on Aug 6, 2020 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 6, 2020 Series B ¥1.29B 2 — — Detail
Jul 2, 2019 Series A ¥0.90B 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
3
Lepu Bio is funded by 3 investors. State New Central Enterprises Operating Investment Fund and Haitong Innovation Capital Management are the most recent investors.
Investor Name Lead Investor Funding Round
State New Central Enterprises Operating Investment Fund — Series B
Haitong Innovation Capital Management — Series B
Sumin Investment — Series A